Validity of the five-word screening test for Alzheimer's disease in a population based study;Le test des 5 mots: Validité dans la détection de la maladie d'Alzheimer dans la population générale

Revue Neurologique

Volumn 161, Issue 12, 2005, Pages 1205-1212

  Cowppli Bony, P ^a,c   Fabrigoule, C ^a   Letenneur, L ^a   Ritchie, K ^a   Alperovitch A ^b   Dartigues, J F ^a   Dubois, B ^b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Alzheimer's disease; Five word test; Memory; Neuropsychology; Screening

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ASSOCIATION; ATTENTION DEFICIT DISORDER; FEMALE; FIVE WORD TEST; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; POPULATION RESEARCH; PREDICTION; RANDOMIZATION; RECALL; SCREENING TEST; SEMANTICS; VALIDATION PROCESS; VERBAL MEMORY;

EID: 30944445393     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(05)85194-x     Document Type: Article

References (53)

1. ALPÉROVITCH A, AMOUYEL P, DARTIGUES JF, DUCIMETIÈRE P, MAZOYER B, RITCHIE K. (2002). Les études épidémiologiques sur le vieillissement en France : de l'étude Paquid à l'étude des trois cités. C R Biologies, 325: 665-672.
2. th ed. Washington.
3. ANAES, SERVICE DES RECOMMANDATIONS ET RÉFÉRENCES PROFESSIONNELLES. (2000). Recommandations pratiques pour le diagnostic de la maladie d'Alzheimer : recommandations pour la pratique clinique. Accésible sur internet : 〈URL/http:// www.anaes.fr/publications/ neurologie
4. AURIACOMBE S, PERE JJ, LORIA-KANZA Y, VELLAS B. (2002). Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donopezil. Curr Med Res Opin, 18: 129-138.
5. BARBERGER-GATEAU P, COMMENGES D, GAGNON M, LETENNEUR L, SAUVEL C, DARTIGUES JF. (1992). Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. JAGS, 40: 1129-1134.
6. e édition française. Paris : Centre de Psychologie Appliquée.
7. BOSS M. (2000). Diagnostic approaches to Alzheimers's disease. Biochim Biophys Acta, 1502: 188-200.
8. BUSCH C, KOZAK J, ELMSLIE T. (1997). Screening for cognitive impairment in the elderly. Can Fam Physician, 43: 1763-1768.
9. BUSCHKE H. (1984). Cued recall in amnesia. J Clin Neuropsychol, 6: 433-440.
10. BUSCHKE H, SLIWINSKI MJ, LIPTON RB. (1997). Diagnosis of early by the double memory test: encoding specificty improves diagnostic sensitivity and specificity. Neurology, 48: 989-997.
11. BUSCHKE H, KULANSKY G, KATZ M, STEWART WF, SLIVINSKI MJ, ECKHOLDT HM, LIPTON RB. (1999). Screening for dementia with the memory impairment screen. Neurology, 52: 231-238.
12. DARTIGUES JF, FABRIGOULE C, LEUTENNEUR L, AMIÉVA H, THIESSARD F, ORGOGOZO JM. (1997). Épidémiologie de la plainte mnésique. In : Michel BF, Derouesné C, Gely-Nargeot MC. EDS. De la plainte mnésique à la maladie d'Alzheimer. Paris : Solal, pp. 41-46.
13. DARTIGUES JF, GAGNON M, MICHEL P et al. (1991). Le programme de recherche Paquid sur l'épidémiologie de la démence. Méthodes et résultats initiaux. Rev Neurol (Paris), 147: 225-230.
14. DARTIGUES JF, HELMER C, DUBOIS B, DUCKAERTS C, LAURENT B, PASQUIER F, TOUCHON J. (2002). La maladie d'Alzheimer, un problème de santé publique : oui. une priorité ? Rev Neurol (Paris), 158: 311-315.
15. DÉROUESNÉ C. (1997). Méconnaissance des déficits mnésiques. In : Michel BF, Derouesné C, Gely-Nargeot MC. EdS. De la plainte mnésique à la maladie d'Alzheimer. Paris : Solal, pp. 57-66.
16. DESGRANGES B, BARON JC, GIFFARD B, LALEVÉE C, VIADER F, DE LA SAYETTE V, EUSTACHE F. (2002). The neural basis of intrusions in free recall and cued recall: A PET study in Alzheimer's disease. Neuroimage, 17: 1658-1664.
17. DUBOIS B, TOUCHON J, PORTET F, OUSSET PJ, VELLAS B, MICHEL B. (2002). Les 5 mots : une épreuve simple et sensible pour le diagnostic de la maladie d'Alzheimer. Presse Med, 31: 1696-1699.
18. ERGIS AM, VAN DER LINDEN M, DEWEER B. (1994). L'exploration des troubles de la mémoire épisodique dans la maladie d'Alzheimer débutante au moyen d'une épreuve de rappel indicé. Rev Neuropsychol, 4: 47-68.
19. EVANS DA, FUNKENSTEIN HH, ALBERT MS et al. (1989). Prevalence of Alzheimer's disease in a comunity of older persons. J Am Med Assoc, 262: 2551-2556.
20. FABRIGOULE C, LECHEVALIER N, CRASBORN L, DARTIGUES JF, ORGOGOZO JM. (2003). Inter-rater reliability of scales and tests used to measure mild Cognitive Impairment by general practitioners and psychologists. Curr Med Res Opin, 19: 603-608.
21. FOLSTEIN MF, FOLSTEIN SE, MC HUGH PR. (1975). "Mini-Mental state". A practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res, 12: 189-198.
22. FURHER R, ROUILLON F. (1989). La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l'échelle d'autoévaluation. Psychiatr Psychobiol, 4: 163-166.
23. GROBER E, BUSCKHE H. (1987). Genuine memory deficits in dementia. Dev Neurpsychol, 3: 13-36.
24. GROBER E, BUSCKHE H, CRYSTAL H, BANG S, DRESNER R. (1988). Screening for dementia by memory testing. Neurology, 38: 900-903.
25. GROSSBERG GT. (2003). Cholinesterase inhibitors for the treatment of Alzheimer's disease: getting on and staying on. Curr Ther Res, 64: 216-235.
26. ISAACS B, AKHTAR A. (1972). The set test: a rapid test of mental function in old people. Age Ageing, 1: 222-226.
27. ISRAEL L. (1996). Échelle d'auto-évaluation des difficultés de la vie quotidienne (Cognitive Difficulties Scale) C.D.S. In : Guelfi JD. EDS. L'évaluation standardisée en psychiatrie. Paris : Solal, pp. 485-491.
28. ISRAEL L. (1996). Questionnaire du fonctionnement de la mémoire. Auto-évaluation des plaintes mnésiques (Memory Functioning Questionnaire) M.F.Q. In : Guelfi JD. EDS. L'évaluation standardisée en psychiatrie. Paris: Édition médicales Pierre Fabre, pp. 493-497.
29. LAWTON MP, BRODY EM. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 9: 179-186.
30. LETENNEUR L, DEQUAE L, JACQUEMIN H et al. (1993). Prévalence de la démence en Gironde (France). Rev Epidemiol Sante Publique, 41: 139-145.
31. LETENNEUR L, GILLERON V, COMMENGES D, HELMER C, ORGOGOZO JM, DARTIGUES JF. (1999). Are gender and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the Paquid project. J Neurol Neurosurg Psychiatry, 66: 177-183.
32. MCKHANN G, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work Group under the auspices of Department Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34: 939-944.
33. MC NAIR DM, KAHN RJ. (1984). Self-assessment o cognitive deficits. In: Crook T, Ferris S, Bartus EDS. Assessment in geriatric psychopharmacology. New Canaan: Mark Powley Associates, pp. 137-143.
34. MORENO MJM. (2003). Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the Acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther, 25: 178-193.
35. O'CONNOR, POLLITT P, HYDE J, BROOCK C, REISS B, ROTH M. (1988). Do general practitioner miss dementia in elderly patients. BMJ, 297: 1107-1110.
36. PALMER AM. (2002). Pharmacotherapy for Alzheimer's disease: progress and prospects. Pharmacol Sci, 23: 426-433.
37. PASQUIER F, GRYMONPREZ L, LEBERT F, VAN DER LINDEN M. (2001). Memory impairment differs in frontotemporal dementia and Alzheimer's disease. Neurocase, 7: 761-771.
38. POITRENAUD J, ISRAEL L, BARRECHE H, LE ROC'H K. (1996). Élaboration d'une version abrégée de l'échelle de difficultés cognitives de Mac Nair et Kahn. In : Michel B, De Rotrou J, Verdureau F EDS. La stimulation cognitive. Paris : Solal, pp. 119-128.
39. POTKIN SG, ANAND R, HARTMAN R, VEACH J, GROOSBERG G. (2002). Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease. Pro Neuropsychopharmacol Biol Psychiatry, 26: 713-720.
40. RADOLOFF L. (1977). The CESD scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1: 385-401.
41. RAMAROSON H, HELMER C, BABERGER-GATEAU, LETENNEUR L. (2002). Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus : données actualisées de la cohorte PAQUID. Rev Neurol, 159: 405-411.
42. REITAN RM. (1965). Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills, 8: 271-276.
43. SCARPINI E, SCHELTENS P, FELDMAN H. (2003). Treatment of Alzheimer's disease: current status and news perspectives. Lancet, 2: 539-547.
44. SCHMAND B, JONKER C, HOOIJER C, LINDEBOOM J. (1996). Subjective memory complaints may annonce dementia. Neurology, 46: 121-125.
45. SKA B, POISSANT A, ROBITAILLE Y, GAUVREAU D, DILHUYDY H. (1998). Profils neuropsychologiques et phénotypes neuropathologiques de patients atteints de la démence de type Alzheimer In : Gely-Nargeot MC, Ritchie K, Touchon J EDS. Actualités sur la maladie Alzheimer et les syndromes apparentés. Paris: Solal, pp. 251-260.
46. TAILLANDIER S, DUCORAIL MA, GERBAUD L, JALENQUES I. (2002). Le dépistage hospitalier des troubles cognitifs chez les patients de plus de 60 ans. Ann Med Psychol, 160: 435-443.
47. THE 3C STUDY GROUP. (2003). Vascular factors and risk of dementia: design of the three-City Study and baseline characteristics of the study population. Neuroepidemiology, 22: 316-325.
48. TOUNSI H, DEWEER B, ERGIS AM, VAN DER LINDEN M, PILLON B, MICHON A, DUBOIS B. (1999). Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease. Alzheimer Dis Assoc Disord, 13: 38-46.
49. VAN DER LINDEN M, WYNS CH, VON FRENKELL R, COYETTE F, SERON X. (1989). Un questionnaire d'auto-évaluation de la mémoire (Memory Functioning Questionaire). Bruxelles : Editest.
50. WESCHLER D. (1975). Weschler memory scale. New York, Psychological Corporation.
51. World Health Organization. (2001). Mental and neurological disorders, fact sheet no 265. December 2001. Avalaible at http:// www.who.int/inf-fs/en/ fact265.html. Acessed October 2003.
52. WOLFSON C, OREMUS M, SHUKLA V, MOMOLI F, DEMERS L, PERRAULT A, MORIDE Y. (2002). Donepezil and Rivastigmine in the treatment of Alzheimer's disease: a best - evidence synthesis of the published data on their efficacy and cost-effectiveness. Clin Ther, 24: 862-886.
53. ZARITT SH. (1982). Affective correlate of self reports about memory of older people. Int J Behaviour Geriatr, 1: 25-34.